These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28188876)

  • 41. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Furan-functionalized co-polymers for targeted drug delivery: characterization, self-assembly and drug encapsulation.
    Shi M; Shoichet MS
    J Biomater Sci Polym Ed; 2008; 19(9):1143-57. PubMed ID: 18727857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters.
    Beck-Broichsitter M; Schmehl T; Gessler T; Seeger W; Kissel T
    J Control Release; 2012 Feb; 157(3):469-77. PubMed ID: 21930166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
    Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
    Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug nanoparticles: formulating poorly water-soluble compounds.
    Merisko-Liversidge EM; Liversidge GG
    Toxicol Pathol; 2008 Jan; 36(1):43-8. PubMed ID: 18337220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advancement of gelatin nanoparticles in drug and vaccine delivery.
    Sahoo N; Sahoo RK; Biswas N; Guha A; Kuotsu K
    Int J Biol Macromol; 2015 Nov; 81():317-31. PubMed ID: 26277745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracellular delivery of proteins by nanocarriers.
    Ray M; Lee YW; Scaletti F; Yu R; Rotello VM
    Nanomedicine (Lond); 2017 Apr; 12(8):941-952. PubMed ID: 28338410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids.
    Simovic S; Barnes TJ; Tan A; Prestidge CA
    Nanoscale; 2012 Feb; 4(4):1220-30. PubMed ID: 22159191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles.
    Wernig K; Griesbacher M; Andreae F; Hajos F; Wagner J; Mosgoeller W; Zimmer A
    J Control Release; 2008 Sep; 130(2):192-8. PubMed ID: 18601963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Encapsulation of antioxidants in gastrointestinal-resistant nanoparticulate carriers.
    Souto EB; Severino P; Basso R; Santana MH
    Methods Mol Biol; 2013; 1028():37-46. PubMed ID: 23740112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PLGA micro and nanoparticles in delivery of peptides and proteins; problems and approaches.
    Mohammadi-Samani S; Taghipour B
    Pharm Dev Technol; 2015 Jun; 20(4):385-93. PubMed ID: 24483777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ceramic nanoparticles: Recompense, cellular uptake and toxicity concerns.
    Singh D; Singh S; Sahu J; Srivastava S; Singh MR
    Artif Cells Nanomed Biotechnol; 2016; 44(1):401-9. PubMed ID: 25229834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
    Moritz M; Geszke-Moritz M
    Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and in vitro evaluation of biocompatible dexamethasone-loaded nanoparticle dispersions, obtained from nano-emulsions, for inhalatory therapy.
    Fornaguera C; Llinàs M; Solans C; Calderó G
    Colloids Surf B Biointerfaces; 2015 Jan; 125():58-64. PubMed ID: 25437064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes.
    Haidar ZS; Hamdy RC; Tabrizian M
    Biomaterials; 2008 Mar; 29(9):1207-15. PubMed ID: 18076987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.